Search Results Heading

MBRLSearchResults

mbrl.module.common.modules.added.book.to.shelf
Title added to your shelf!
View what I already have on My Shelf.
Oops! Something went wrong.
Oops! Something went wrong.
While trying to add the title to your shelf something went wrong :( Kindly try again later!
Are you sure you want to remove the book from the shelf?
Oops! Something went wrong.
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
    Done
    Filters
    Reset
  • Discipline
      Discipline
      Clear All
      Discipline
  • Is Peer Reviewed
      Is Peer Reviewed
      Clear All
      Is Peer Reviewed
  • Series Title
      Series Title
      Clear All
      Series Title
  • Reading Level
      Reading Level
      Clear All
      Reading Level
  • Year
      Year
      Clear All
      From:
      -
      To:
  • More Filters
      More Filters
      Clear All
      More Filters
      Content Type
    • Item Type
    • Is Full-Text Available
    • Subject
    • Country Of Publication
    • Publisher
    • Source
    • Target Audience
    • Donor
    • Language
    • Place of Publication
    • Contributors
    • Location
166,935 result(s) for "Consciousness"
Sort by:
Alterations of consciousness and mystical-type experiences after acute LSD in humans
Rationale Lysergic acid diethylamide (LSD) is used recreationally and in clinical research. Acute mystical-type experiences that are acutely induced by hallucinogens are thought to contribute to their potential therapeutic effects. However, no data have been reported on LSD-induced mystical experiences and their relationship to alterations of consciousness. Additionally, LSD dose- and concentration-response functions with regard to alterations of consciousness are lacking. Methods We conducted two placebo-controlled, double-blind, cross-over studies using oral administration of 100 and 200 μg LSD in 24 and 16 subjects, respectively. Acute effects of LSD were assessed using the 5 Dimensions of Altered States of Consciousness (5D-ASC) scale after both doses and the Mystical Experience Questionnaire (MEQ) after 200 μg. Results On the MEQ, 200 μg LSD induced mystical experiences that were comparable to those in patients who underwent LSD-assisted psychotherapy but were fewer than those reported for psilocybin in healthy subjects or patients. On the 5D-ASC scale, LSD produced higher ratings of blissful state, insightfulness, and changed meaning of percepts after 200 μg compared with 100 μg. Plasma levels of LSD were not positively correlated with its effects, with the exception of ego dissolution at 100 μg. Conclusions Mystical-type experiences were infrequent after LSD, possibly because of the set and setting used in the present study. LSD may produce greater or different alterations of consciousness at 200 μg (i.e., a dose that is currently used in psychotherapy in Switzerland) compared with 100 μg (i.e., a dose used in imaging studies). Ego dissolution may reflect plasma levels of LSD, whereas more robustly induced effects of LSD may not result in such associations.
Cognitive Motor Dissociation in Disorders of Consciousness
Among 241 persons with disorders of consciousness who had no observable response to commands, 25% had a verifiable response to commands on EEG or functional MRI, a condition known as cognitive motor dissociation.
The autonomic response following taVNS predicts changes in level of consciousness in DoC patients
Advancements in emergency medicine and critical care have significantly improved survival rates for patients with severe acquired brain injuries(sABI), subsequently increasing the prevalence of disorders of consciousness (DoC) such as Unresponsive Wakefulness Syndrome (UWS) and Minimally Conscious State (MCS). However, the assessment of conscious states relies on the observation of behavioral responses, the interpretation of which may vary from evaluator to evaluator, as well as the high rate of misdiagnosis, which together pose significant challenges for clinical diagnosis. The study investigates the utility of transcutaneous auricular vagus nerve stimulation (taVNS) in modulating autonomic responses, as evidenced through heart rate variability (HRV), for distinguishing between healthy individuals and DoC patients and for prognosticating patient outcomes. A prospective randomized clinical trial was conducted from Februry 9, 2022, to February 4, 2024, at Hangzhou Armed Police Hospital in China. Healthy controls (HC) and DoC patients were enrolled in this study. The taVNS was administered to each subject for ten minutes. There electrocardiogram (ECG) signals were recorded for the analysis of HRV both during the stimulation and the ten minutes of rest that preceded and followed the stimulation. Subsequent investigations utilized Support Vector Machine (SVM) modeling, enhanced by a Radial Basis Function (RBF) kernel, to explore potential predictors of patient outcomes. This approach aimed to differentiate HC from DoC and MCS from UWS patients. 26 HC and 36 patients diagnosed with DoC were included in the analysis,. The DoC group consisted of 17 patients with a diagnosis of MCS and 19 with diagnosis of UWS/VS. Significant modulations in HRV parameters (HF, VLF, SampEn) were observed, indicating variations in autonomic response between the control group and DoC patients. Using the VLF, LF, and SampEn features in SVM model, DoC and HC were correctly classified with an accuracy of 86%. Similarly, MCS and UWS were classified with an accuracy of 78%. The SVM modeling achieved an 86% accuracy rate in predicting outcomes three months post-intervention, with a 71% confirmation rate at six months.The results highlight taVNS’s potential as a therapeutic modality in managing DoC by demonstrating its impact on autonomic regulation and suggesting pathways for enhancing recovery, which accentuates the significance of exploring brain-heart dynamics in DoC, presenting a novel approach to therapeutic strategies. Trial Registration Information : URL: chictr.org.cn; Unique identifier: ChiCTR2100045161. Date of the first registration: 9th/ April/ 2021.
Stream of Consciousness
To the Editor: Blum and colleagues (April 5 issue) 1 report an interesting and instructive but unusual case of the posterior reversible encephalopathy syndrome (PRES) resulting from a common condition — obstructive uropathy related to benign prostatic hyperplasia. We would like to point out that the diagnosis was delayed by approximately 48 hours because ultrasonographic examination of the urinary tract was not performed in a timely manner. Early exclusion of obstruction is emphasized as a time-tested teaching point in patients presenting with azotemia and uremia because prompt reversal or clinically significant improvement is common after a (usually) simple intervention if the . . .
280 A screening questionnaire for transient loss of consciousness
BackgroundTransient loss of consciousness (TLOC) is a common primary care presentation. 90% are due to syncope (S), epilepsy (E), or psychogenic non-epileptic seizures (PNES). Misdiagnosis and delayed diagnosis is common. We explore symptoms and witness observations that can classify patients with likely diagnoses of E, S, or PNES.MethodsPatients with objectively-documented diagnoses of E, S, or PNES, and an attack witness, were invited to complete a questionnaire (capturing medical history, 86 peri-episodal experiences, and 31 witness observations). Iterative feature selection identified questions strongly predictive of diagnosis; a random forest trained on these classified patients into likely diagnoses of E, S, or PNES.Results249 patients (86 E, 79 s, 84 PNES) were randomly assigned to training or validation in a 2:1 ratio. Feature selection identified 36 highly-predictive questionnaire items. The classifier correctly diagnosed 86% of patients in validation. 100% of S were correctly diagnosed, 85.7% E and 75% PNES. A simpler 12-feature model correctly classified 76.7% of cases (E: 75%; S: 92.3%; PNES: 65.6%).ConclusionsTLOC-associated symptoms and manifestations can contribute to a decision rule for primary/emergency care, assisting triage and referral. Determining a diagnostic pre-test probability from TLOC features can aid interpretation of investigation abnormalities of uncertain significance.